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SUMMARY
HIV-1 replicates in activated T cells at significantly higher levels than in resting cells. Thus, certain
molecules up-regulated during T cell activation appear to be important for HIV-1 replication. In this
study, we present evidence suggesting that expression of MHC class II (class II) molecules on CD41 T
cells facilitate HIV-1 replication. T cells that expressed class II supported greater virus replication than T
cells lacking class II. The class II1 cells, when either infected with HIV-1 or transfected with an env-
minus HIV-1 provirus plasmid, produced 10±20-fold greater virus expression than class II2 cells. Anti-
class II antibody markedly inhibited virus expression in class II1 cells (but not class II2 cells) and also
decreased the nuclear binding activity of AP-1, an inducible transcription factor important in T cell
activation and HIV-1 expression. Most importantly, the induction of class II expression by transfection
of the MHC class II transactivator (CIITA) stimulated HIV-1 replication in Jurkat T cells. Taken
together, these data suggest that expression of MHC class II molecules and/or CIITA in T cells enhances
HIV-1 transcription.
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INTRODUCTION
The primary receptor for HIV-1 infection, CD4, is expressed mainly
on T lymphocytes, monocytes/macrophages and dendritic cells.
Although a variety of cell types can be infected by HIV-1, CD41 T
cells are the predominant cell types found infected in both lymph
nodes and in the peripheral blood [1±3]. In addition, most of the
viral burden in blood plasma is derived from infected CD41 T cells
[3±6]. HIV-1 binds to and fuses with the membrane of T cells via
interactions with CD4 and chemokine co-receptor, but replicates at
high levels only in T cells that have been activated [7±9].
Although undetectable on resting T cells, MHC class II
molecules are expressed to a high level on activated T cells. The
role of class II molecules constitutively expressed on antigen-
presenting cells (APC) is well documented with regard to antigen
presentation to CD41 T cells. However, the function of class II on
activated CD41 T cells is unclear, although some reports suggest
that under certain circumstances class II on T cells can also
present antigen [10±12]. Following interaction with CD4 on the
antigen receptor-bearing cells, class II molecules on B cells have
been reported to transduce intracellular signals involving activa-
tion of protein kinase C (PKC), tyrosine kinases, phospholipase C,
and the mobilization of intracellular calcium [13±16]. These class
II-mediated signals are associated with either apoptosis or
activation of cells depending on the activation and/or differentia-
tion state of the cells [17,18]. Class II expression on T cells can
also transmit intracellular signals [19±23]. Antibody cross-linking
of HLA-DR has been shown to induce Ca21 flux as well as
tyrosine phosphorylation of several intracellular proteins in both B
and T cells [21,24±27].
Several host cell proteins including MHC class I and II are
physically incorporated into the HIV-1 membrane, where they
remain functional [28±31]. Incorporation of class I and class II
molecules has been shown to render the HIV-1 virions more
infectious [32,33]. We showed that virions can transfer HLA-DR
molecules from activated host cells to target cells during virus±
cell fusion, enabling this protein potentially to contribute to cell
activation and virus replication [34].
Class II expression is regulated by the class II transactivator
(CIITA), which is recruited to the class II promoter by sequence-
specific DNA binding proteins [35±38]. CIITA functions as a
master switch for the activation of the class II promoter, resulting
in surface expression of class II molecules in activated T cells.
However, the relationship between class II expression and HIV-1
replication has not been investigated. We demonstrate here that
HIV-1 expression is significantly greater in class II1 T cells and
that the class II transactivator can increase virus expression.
MATERIALS AND METHODS
Cells and viruses
The H9 (HTB 176) and Jurkat (TIB 152) cells (American Type
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Culture Collection (ATCC), Rockville, MD), HPB-ALL [39] and
CEM (T1 and T2) cells (obtained from P. Cresswell, Yale
University, New Haven, CT) were grown in RPMI 1640 medium
(Whittaker Bioproducts, Walkersville, MD) supplemented with
10% heat-inactivated fetal bovine serum (FBS; Hyclone, Logan,
UT).
HIV-1 was obtained from H9 or CEM cells infected with the
HIV-1MN strain (NIH AIDS Research and Reference Reagent
Program, Rockville, MD). Cells were acutely infected with HIV-
1MN and virus stocks prepared following standard procedure [40].
The amount of virus was quantified by measuring p24 antigen in
the culture supernatant by ELISA (Coulter Co., Hialeah, FL).
Antibodies and expression plasmids
Mouse hybridoma HB-55 (L243) producing anti-HLA-DR and
HD-245/332 (SD1744) producing anti-CD25 (anti-Tac) antibody
were obtained from ATCC. Mouse hybridoma Sim.4 producing
anti-human CD4 antibody was obtained from NIH AIDS Research
and Reference Reagent Program. PE-conjugated antibody to
HLA-DR, CD3, CD4, CD25, CD28, CD38 and isotype control
IgG were obtained from Becton Dickinson (San Jose, CA), and
PE-conjugated antibody to human CXCR4 was obtained from
PharMingen (San Diego, CA).
The pNL4-3.Luc.R2E2 (pNL4-3LucE2), an env-minus HIV-1
provirus plasmid that expresses firefly luciferase, was obtained
from NIH AIDS Research and Reference Reagent program
(contributed by N. Landau, Aaron Diamond AIDS Research
Center, New York, NY). The pRL-TKLuc construct, which
expresses Renilla luciferase driven by the herpes simplex virus
thymidine kinase promoter, was purchased from Promega Corp.
(Madison, WI). The pcDNACIITA-6, human MHC class II
transactivator plasmid was prepared as described [41].
Stable induction of class II in Jurkat cells
Jurkat T cells (107) were transfected with 25 mg of pcDNACII-
TA-6 and 1 mg of neomycin DNA by electroporation using Gene
Pulser Transfection Apparatus (BioRad, Richmond, CA) accord-
ing to the manufacturer's protocol. Briefly, cells were transferred
into an ice-cold Gene Pulser cuvette (0´4 cm) and subjected to a
single pulse at 960 mF and 300 V. After shocking, the cuvette was
incubated on ice for 10 min before cells were transferred to
culture medium containing 10% FBS and 1 mg/ml G418
(Calbiochem, La Jolla, CA). After 3 weeks of culture in the
presence of 1 mg/ml G418, the selected class II1 cells were
maintained at 500 mg/ml of G418. Surface expression of class II
induced by CIITA was confirmed by flow cytometry.
Infection and binding of HIV
Cells (106) were infected for 2 h at 378C with HIV-1MN
(multiplicity of infection 0´01) derived from H9 cells. In some
infection experiments, cells and viruses were preincubated
separately with or without anti-HLA-DR (L243), anti-CD25
(anti-Tac) or anti-CD4 (Sim.4) antibody (3 mg/ml) for 30 min
at room temperature before they were mixed for further incubation
at 378C for 2 h. After infection, cells were washed and cultured in
96-well plates (Coster, Cambridge, MA) (20 000 cells/well in
200 m l) in the presence or absence of antibody (3 mg/ml). At
6 days post-infection, supernatants were treated with 0´5% Triton
X-100 and analysed for p24 antigen by ELISA. Jurkat cells
expressing or lacking class II were infected with HIV-1MN at a
MOI of 0´001. After 6 days cell supernatants were harvested and
analysed as above.
To measure virus binding to cells, 2  106 CEM cells (T1 or
T2) and HIV-1MN virus (20 ng p24) were preincubated separately
for 30 min on ice in the presence or absence of anti-HLA-DR
(L243) or anti-CD4 (Sim.4) antibody (3 mg/ml). Virus and cells
were then mixed and further incubated for 2 h on ice. Cells were
washed to remove unbound virus, lysed with 1% Triton X-100 and
analysed for cell-bound HIV by p24 ELISA.
Transfection and reporter gene assays
CEM-T1 and CEM-T2 cells were transiently transfected with the
pNL4-3LucE2 construct using DMRIE-C reagent (Gibco BRL,
Grand Island, NY) according to the manufacturer's protocol.
Briefly, DNA complexes were prepared by incubating 4 mg of
pNL4-3LucE2 DNA and 6 m l of DEMRIE-C reagent in 1 ml of
opti-MEM medium (Gibco BRL) for 45 min at room temperature.
Cells (2  106) were washed with serum-free medium, incubated
with the DNA mixture for 3±4 h at 378C. The transfected cells
were cultured in RPMI 1640 medium supplemented with 1% FBS
(2  105/well per ml) in 48-well plates for 72 h when cells and
supernatants were harvested. HIV expression was determined in
the cell lysates using the Luciferase Assay System (Promega) and
by measuring p24 antigen in the supernatant by ELISA. In some
experiments, cells (2  106) were co-transfected with 4 mg of
pNL4-3LucE2 and 100 ng of pRL-TK DNA as described above
and analysed using the Dual-Luciferase Reporter Assay System
(Promega) to compare the viral expression and transfection
efficiency between the two cell types.
In some experiments, cells were transfected with pNL4-
3LucE2 DNA as above and cultured in the presence or absence of
MoAb to HLA-DR or CD25 before analysis for luciferase activity.
DNA binding studies
Electrophoretic mobility shift assays (EMSA) were performed as
described [42]. Briefly, CEM-T1 or CEM-T2 cells (5  106) were
preincubated with or without L243 antibody (5 mg/ml) for 60 min
at 378C, and then nuclear protein extracts were prepared as
described [43]. Protein extracts (5 mg) were incubated with
50 000 ct/min (approx. 0´1 ng) of 32P end-labelled consensus NF-
kB binding oligonucleotide probe (5 0-AGTTGAGGG-
GACTTTCCCAGGC-3 0) or consensus AP-1 probe (5 0-
CGCTTGATGAGTCAGCCGGAA-3 0) for 20±30 min at room
temperature in a 10-m l reaction volume containing 12% glycerol,
12 mm HEPES-NaOH pH 7´9, 60 mm KCl, 5 mm MgCl2, 4 mm
Tris±HCl pH 7´9, 0´6 mm EDTA, 0´6 mm DTT, and 0´25 mg
double-stranded poly (dI-dC). Protein±DNA complexes were
resolved in 5% polyacrylamide gels pre-electrophoresed for
30 min at room temperature in 0´25  TBE buffer (22´5 mm
Tris-borate and 0´5 mm EDTA, pH 8´3). Gels were dried and
exposed to radiographic film with an intensifying screen.
Measurement of cytokine and chemokine
CEM-T1 and CEM-T2 cells (106/ml) were cultured for 2 days.
Cytokine and chemokine levels in cell-free supernatants were
measured by immunoreactivity in a double-sandwich ELISA
format using commercially available kits for IL-1b , IL-2, IL-4,
IL-6, interferon-gamma (IFN-g), tumour necrosis factor-alpha
(TNF-a ) and RANTES (Biosource Int., Camarillo, CA), and for
macrophage inflammatory protein (MIP)-1a and MIP-1b (R&D
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Systems, Minneapolis, MN). All assays were performed according
to manufacturers' protocols.
RESULTS
Class II1 T cells support greater HIV-1 replication
While assessing HIV-1 infection in several cell lines we noticed
that virus replicated to significantly higher levels in class II1 T
cells than in class II2 cells. For example, virus replicated to eight-
fold higher levels in class II1 H9 cells than in class II2 HPB-ALL
cells (Fig. 1a).
We also analysed virus replication in CEM-T1 and CEM-T2
cells, two CD41 T cell lines derived from the same parental cell
that are class II1 and class II2, respectively. The CEM-T1 cells
supported significantly greater HIV-1 replication (7´5-fold) than
the CEM-T2 cells (Fig. 1b), while the two cell lines expressed
similar levels of cell surface CD4 and chemokine receptor
CXCR4 (data not shown).
To determine whether soluble factors secreted by the cells
were responsible for the different levels of virus replication,
various cytokines and chemokines were measured in the culture
supernatants. While IL-1b , IL-2, IL-4, IL-6, IFN-g and TNF-a
were undetectable in supernatants from either cell, high levels of
RANTES (4000±6000 pg/ml) were secreted from both cell types.
While 2000±4000 pg/ml of both MIP-1a and MIP-1b were
detected in supernatants from CEM-T2 cells, both chemokines
were undetectable in CEM-T1 cells. To determine the effects on
HIV expression of either MIP-1 secretion or other soluble factors
produced by the cells, CEM-T1 and CEM-T2 cells were infected
and treated with 3%, 10% and 20% of supernatant from the other
cell type. In both cases, the level of virus expression was
unaffected (data not shown). These experiments indicate that the
differential HIV-1 expression by CEM-T1 and CEM-T2 cells was
not due to soluble factors secreted in the culture supernatants.
Anti-HLA-DR antibody inhibits HIV-1 replication
Since expression of class II was associated with higher HIV
replication in these cells, we next investigated the effect of
treatment of cells with antibody to HLA-DR (L243) on virus
replication. As shown in Fig. 1a, L243 significantly reduced the
replication of virus in H9 cells, while virus replication was
unaffected in class II2 HPB-ALL cells. Treatment with anti-CD25
antibody did not have a significant effect on virus replication,
while anti-CD4 antibody (Sim.4) as expected inhibited virus
replication in both cell types (data not shown). The L243 antibody















































Fig. 1. Class II1 T cells support greater HIV-1 replication and anti-class
II antibody inhibits virus replication. Class II1 H9 and class II2 HPB-ALL
cells (a), and class II1 CEM-T1 and class II2 CEM-T2 cells (b), were
infected with HIV-1MN in the presence or absence of anti-HLA-DR
(L243), anti-Tac, or anti-CD4 (Sim.4) antibody (3 mg/ml). HIV-1
replication was assessed after 6 days by measuring p24 antigen in the
culture supernatants by ELISA. The results represent the mean of three



























Fig. 2. Anti-class II antibody does not inhibit HIV-1 binding to cells
expressing class II. CEM-T1 and CEM-T2 cells and HIV-1MN virus were
incubated separately with anti-HLA-DR (L243) or anti-CD4 (Sim.4)
antibody for 30 min at room temperature. The virus and cells were then
mixed and further incubated for 2 h on ice. The cells were washed, lysed
with Triton X-100 and cell-bound virus measured by p24 antigen ELISA.
The data represent the mean of three experiments 1 s.d.
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in CEM-T2 cells, while the anti-CD4 antibody inhibited virus
replication in both cell lines (Fig. 1b). Anti-CD25 had no
significant effect on virus replication in either CEM-T1 or
CEM-T2 cells (Fig. 1b).
To determine if the L243 antibody interfered with HIV-1
binding to cells, and thereby inhibited infection, we assessed the
effects of L243 on virus binding to CEM-T1 and CEM-T2 cells.
As shown in Fig. 2, L243 treatment did not significantly affect
binding of HIV-1 to either of the cell lines, while the anti-CD4
antibody inhibited virus binding to both cell types. The anti-CD4
antibody inhibited virus binding by only 25±45%, suggesting cell
surface molecules other than CD4 can contribute to virus binding.
This finding is consistent with previous reports that suggested that
the interaction between virion and other cell surface proteins can
be stronger than the CD4-mediated virus attachment [44]. This is
also consistent with a previous report that HIV can bind HeLa
cells independent of CD4 [45]. These results show that the
inhibition of virus replication in class II1 cells by L243 antibody
was not due to a reduction in virus binding to the cell surface.
Another possible explanation for L243 inhibition of virus
expression is decreased cell proliferation induced by the antibody.
However, treatment of cells with L243 produced no significant
change in 3H-thymidine incorporation (data not shown), indicating
that the antibody inhibition of virus replication was not due to
decreased cell proliferation.
MHC class II expression is associated with increased HIV-1
provirus expression
To investigate the mechanism by which class II expression could
affect HIV-1 expression, we performed a series of comparative
functional studies in the CEM-T1 and CEM-T2 cell lines. We first
examined whether class II expression is associated with
intracellular provirus expression, by transfecting the CEM cells
with pNL4-3LucE2, an envelope minus HIV-1 proviral plasmid
containing a firefly luciferase reporter gene. Supernatants were
assessed for p24 production by ELISA, and the cell lysates
analysed for luciferase activity 72 h after transfection. Since this
provirus lacks the env gene, the virus produced from transfection
cannot bind and infect new cells, limiting virus replication to the
initial round of infection. As shown in Fig. 3, HIV-1 expression
was markedly higher in class II1 CEM-T1 cells than in class
II2CEM-T2 cells with p24 core antigen expression 10-fold higher
(Fig. 3a), and provirus-mediated luciferase activity 20-fold higher
(Fig. 3b). The large difference between cells in p24 production
and luciferase expression was observed with either 0´5, 1´0 or
2´0 mg of transfected DNA (data not shown). These studies
demonstrate that the higher HIV-1 expression in CEM-T1 cells is
primarily due to an intracellular mechanism and not due to
increased virus binding, entry or secondary rounds of infection.
To ensure equivalent transfection efficiencies in the two cell
types, we co-transfected a second reporter plasmid expressing
Renilla luciferase. As shown in Fig. 3c, Renilla luciferase activity
was not significantly different between class II1 and class II2
cells, demonstrating that the transfection efficiency of the two cell
lines was similar. In addition, because the Renilla luciferase gene
is driven by the herpesvirus thymidine kinase promoter, these data
indicate that the low virus expression in the class II2 cell line was
not due to a general transcriptional defect. Thus, it appears that the
marked increase in virus expression in class II1 cells is mediated
at the level of HIV transcription.
We next examined the effect of the L243 antibody on provirus
expression in the two cell types. As shown in Fig. 4, L243
inhibited provirus-mediated luciferase activity in a dose-depen-
dent manner in CEM-T1 cells. In contrast, the antibody had little
or no effect on provirus expression in CEM-T2 cells. The L243
antibody had no effect on Renilla luciferase expression in either
CEM-T1 or CEM-T2 cells (data not shown). The antibody effect
was specific, since an anti-CD25 antibody had no effect on
provirus expression (Fig. 4). These results show that the L243
antibody inhibits virus transcription and suggests either that HLA-
DR on CD41 T cells transmits an intracellular activation signal
important for efficient virus expression that is blocked by L243, or
that binding of L243 induces a negative signal for virus
expression.
HIV-1 expression is dependent on host-cell transcription
factors interacting with cis-elements in the promoter region of the
viral LTR [46]. Two inducible transcription factors, AP-1 and NF-
kB, have been demonstrated to play important roles in both T cell
activation and HIV-1 replication [42,47±49]. To determine
whether L243 antibody treatment affects the availability of these
transcription factors, the two CEM cell lines were treated with
L243 for 60 min and nuclear protein extracts were assessed for
DNA binding activity by gel mobility shift analysis. As shown in
Fig. 5, the class II1 and class II2 cells showed marked differences
in the DNA binding activity of these two transcription factors. In
CEM-T1 cells, the AP-1 binding was approximately 90% greater
than in CEM-T2 cells. Similarly, NF-kB binding activity was also
consistently greater in CEM-T1 than in CEM-T2 cells. Im-
portantly, L243 had a marked inhibitory effect on AP-1 binding
activity in CEM-T1 cells. In contrast, the antibody had little or no
effect on the NF-kB binding activity in either cell type or the AP-
1 binding activity in CEM-T2 cells. These data show that class II1
and class II2 cells have different amounts of nuclear transcription
factors available for T cell activation and that treatment with
antibody to class II can affect the availability of transcription
factor.
Expression of CIITA increases HIV-1 expression in Jurkat T cells
To assess more directly whether class II expression increases
HIV-1 expression, we created a cell line that constitutively
expresses class II by stably transfecting Jurkat cells with the MHC
class II transactivator, CIITA. While untransfected Jurkat cells are
HLA-DR2, a high level of HLA-DR (99% positive) was induced
in the CIITA transfected Jurkat cells (Jurkat-DR). The expression
of other surface proteins, including CD3, CD4, CD25, CD28,
CD38 and CXCR4, remained essentially unchanged after
transfection (data not shown).
To determine the effect of CIITA transfection on virus
replication, the Jurkat and Jurkat-DR cell lines were infected with
HIV-1MN. As shown in Fig. 6, HIV-1 replicated five-fold higher
in Jurkat-DR cells than in Jurkat cells. This result demonstrates
that the induction of class II expression by CIITA in Jurkat T cells
is associated with an activation of HIV-1 expression.
DISCUSSION
In this study, we provide the first evidence that class II expression
on CD41 T cells contributes to HIV-1 replication. We found that
the level of HIV-1 replication in class II1 T cells was significantly
greater than in class II2 cells, irrespective of whether the virus
was introduced into the cells by infection or by transfection of a
provirus construct. The differential virus expression observed in
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class II1 CEM-T1 and class II2 CEM-T2 cells (which are derived
from the same parental cells) suggested that the event of class II
expression in T cells is critically involved in the activation of
HIV-1 expression. This conclusion is directly supported by the
association of increased HIV-1 expression in Jurkat cells in which
class II expression was induced by the stable introduction of a
CIITA expression plasmid.
HIV-1 does not replicate efficiently in primary resting T cells,
and although there is no true resting T cell line available, the
markedly different viral expression displayed in these two pairs of
T cell lines (CEM and Jurkat) as well as in H9 and HPB-ALL cells
probably reflects differences in cellular activation states. More-
over, Jurkat cells produced approximately five-fold more virus
when class II was induced on their surface, indicating class II
expression in Jurkat cells provided an activation signal to drive
increased virus replication. A recent report showed that both
resting memory and naive T cells contain virus in vivo, since
replication-competent virions can be obtained from both cell types
upon in vitro stimulation [50]. Although that study did not assess
virus replication in memory or naive cells, the results of our
studies suggest that class II expression induced in either cell type
could increase virus replication.
Immune activation plays an important role in HIV-1 replica-
tion in T cells [51±54], and the level of expression of HLA-DR on
CD41 T cells directly correlates with cell cycling and disease
severity in HIV infection [55±57], suggesting that class II
expression in T cells plays a significant role in HIV-1 replication.
The hypothesis that the state of cellular activation as marked by
class II expression leads to increased virus expression in T cells is
supported by the fact that class II molecules are known to
transduce activation signals in both B and T cells [18,19,22,23],
and that anti-HLA-DR antibodies can block these activation
signals [58±60]. Consistent with previous reports, class II1 CEM-
T1 cells showed increased nuclear binding activity of the cellular
transcription factors AP-1 and NF-kB, both of which are known to
be important for T cell activation and HIV-1 expression [47±
49,61]. Moreover, AP-1 binding was down-regulated in CEM-T1



























































Fig. 3. Cells expressing class II support greater HIV-1 provirus expression. CEM-T1 cells expressing class II and CEM-T2 lacking class II
were co-transfected with the plasmid pNL4-3LucE2 and pTK Renilla-Luc. Cells were cultured for 72 h when cell supernatants and cell
lysates were analysed for viral expression by measuring p24 antigen (a) and firefly luciferase activity (b), respectively. Transfection
efficiency was also assessed in the same cell lysate by measuring Renilla luciferase activity using Stop and Glo reagent (c). The data
represent the mean of three experiments 1 s.d.

























Fig. 4. Anti-class II antibody reduces HIV-1 provirus expression in class
II1 cells. CEM-T1 (B) and CEM-T2 cells (A) were transfected with the
HIV-1 plasmid pNL4-3LucE2. Transfected cells were cultured for 48 h
with increasing concentrations of L243 antibody (0±3 mg/ml). Cells were
lysed and provirus expression was determined by measuring luciferase
activity. Anti-CD25 antibody (3 mg/ml) was used as an isotype control.
The data represent the mean of three experiments 1 s.d.
Fig. 5. Anti-class II antibody inhibits AP-1 but not the NF-kB binding
activity in class II1 cells. Nuclear protein extracts from CEM-T1 and
CEM-T2 cells which were pretreated for 60 min with or without L243
antibody (5 mg/ml) were assessed for AP-1 and NF-kB binding activity by
gel-shift assay as described in Materials and Methods. A representative
autoradiogram is shown. The free probe, which migrates to the bottom of
the gel, is not shown. Note that the AP-1 and NF-kB binding activity is
greater in the class II1 CEM-T1 cells and the L243 antibody markedly
inhibits the AP-1 but not the NF-kB binding activity. The data represent
one of three similar experiments.
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class II-mediated activation signals to increase provirus expression.
Although it is not known whether class II expression directly activates
the provirus through AP-1, we and others have shown that AP-1
binding sites in the 5 0-untranslated leader region can contribute to
HIV-1 expression in T cells and monocyte/macrophages [46,49].
Additional studies will be required to identify the viral elements and
factors that are targeted by class II activation signals.
It has been demonstrated that HIV-1 particles contain an
abundance of cellular HLA-DR that can enhance virus replication
in target cells [28,32,62]. Increased virus replication may be due
to enhanced virus binding, since HLA-DR can physically interact
with CD4 independent of antigen processing and presentation
[63±65]. In addition to the effect of virion-associated HLA-DR on
virus infectivity, our results strongly suggest that class II
molecules on the surface of host cells also play an important
role in HIV replication by affecting transcription. Furthermore,
HLA-DR antibody could inhibit virus expression in class II1 cells,
but not in class II2 cells. The effect of anti-class II antibody in
HIV infection is consistent with previous studies [66,67].
Interestingly, a state of immune activation in HIV-infected
individuals is further supported by the up-regulation of HLA-
DR expression on CD41 T cells [68]. In addition, some in vitro
studies also suggest that HIV-1 infection may involve binding to
or modulation of HLA-DR expression on host cells [67,69]. Taken
together, these results indicate that MHC class II molecules play
an important role in HIV-1 replication whether they are on the
virion or on the host cell.
MHC class II expression on activated T cells has long been
suggested to contribute to immunoregulation and AIDS pathogen-
esis [66,70±73]. In this regard, several mechanisms have been
proposed, such as presentation of endogenously synthesized HIV-
1 envelope antigen by T cells, clonal inactivation of virus-specific
T cells due to cell±cell interaction, and molecular mimicry
between HIV-1 envelope and class II molecules. Moreover, a
recent report suggested that HIV-1 infection causes down-
regulation of MHC class II expression on target cells [74].
The data here provide the first evidence that the events leading
to class II expression on CD41 T cells induce HIV-1 expression.
However, the precise mechanisms of HIV-1 induction are not
clear and require further investigation. We are currently exploring
two possible mechanisms. The first involves the role of CIITA on
the activation of the HIV-1 LTR, and the second concerns the
class II signalling of HIV-1. These mechanisms are not mutually
exclusive and it is possible that both may contribute to the
enhancement of HIV-1 expression in activated T cells. We
recently demonstrated that CIITA can directly activate the HIV-1
LTR via a transcriptional mechanism similar to that used by
CIITA to activate class II gene expression [75]. Understanding
class II-mediated HIV-1 expression may provide new targets or
strategies for the development of an effective therapy against HIV
disease.
ACKNOWLEDGMENTS
This research was supported by the American Cancer Society IL Division
grant 96-43, and the NIH Grant AI 31812. We thank Professors Tom Lint
and Mark Peeples for their constructive criticism, and Tarlan Hedayati and
Yvonne Albert for their technical assistance.
REFERENCES
1 Zhang Z, Schuler T, Zupancic M et al. Sexual transmission and
propagation of SIV and HIV in resting and activated CD4(1) T cells.
Science 1999; 286:1353±7.
2 Chun TW, Carruth L, Finzi D et al. Quantification of latent tissue
reservoirs and total body viral load in HIV-1 infection. Nature 1997;
387:183±8.
3 Perelson AS, Neumann AU, Markowitz M et al. HIV-1 dynamics in
vivo: virion clearance rate, infected cell life-span, and viral generation
time. Science 1996; 271:1582±6.
4 Finzi D, Silliciano RF. Viral dynamics in HIV-1 infection. Cell 1998;
93:665±71.
5 Ho DD, Neumann AU, Perelson AS et al. Rapid turnover of plasma
virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;
373:123±6.
6 Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human
immunodeficiency virus type 1 infection. Nature 1995; 373:117±22.
7 Stevenson M, Stanwick TL, Dempsey MP et al. HIV-1 replication is
controlled at the level of T cell activation and proviral integration.
EMBO J 1990; 9:1551±60.
8 Wong JK, Hezareh M, Gunthard HF et al. Recovery of replication-
competent HIV despite prolonged suppression of plasma viremia.
Science 1997; 278:1291±5.
9 Zack JA, Arrigo SJ, Weitsman SR et al. HIV-1 entry into quiescent
primary lymphocytes: molecular analysis reveals a labile, latent viral
structure. Cell 1990; 61:213±22.
10 Brown MF, Cook RG, Van M et al. Cloned human T cells synthesize
Ia molecules and can function as antigen presenting cells. Hum
Immunol 1984; 11:219±28.
11 Gerrard TL, Volkman DJ, Jurgensen CH et al. Activated human T cells
can present denatured antigen. Hum Immunol 1986; 17:416±25.
12 Lanzavecchia A, Roosnek E, Gregory T et al. T cells can present
antigens such as HIV gp120 targeted to their own surface molecules.
Nature 1988; 334:530±2.
13 Brick-Ghannam C, Huang FL, Temime N et al. Protein kinase C
(PKC) activation via human leucocyte antigen class II molecules. A
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